443 related articles for article (PubMed ID: 29984400)
21. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
[TBL] [Abstract][Full Text] [Related]
22. A face-to-face comparison of claudin-5 transduced human brain endothelial (hCMEC/D3) cells with porcine brain endothelial cells as blood-brain barrier models for drug transport studies.
Gericke B; Römermann K; Noack A; Noack S; Kronenberg J; Blasig IE; Löscher W
Fluids Barriers CNS; 2020 Aug; 17(1):53. PubMed ID: 32843059
[TBL] [Abstract][Full Text] [Related]
23. Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells.
Ohtsuki S; Sato S; Yamaguchi H; Kamoi M; Asashima T; Terasaki T
J Cell Physiol; 2007 Jan; 210(1):81-6. PubMed ID: 16998798
[TBL] [Abstract][Full Text] [Related]
24. Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation.
Ivan DC; Walthert S; Locatelli G
Front Immunol; 2021; 12():666961. PubMed ID: 33936108
[TBL] [Abstract][Full Text] [Related]
25. Astrocytic TYMP and VEGFA drive blood-brain barrier opening in inflammatory central nervous system lesions.
Chapouly C; Tadesse Argaw A; Horng S; Castro K; Zhang J; Asp L; Loo H; Laitman BM; Mariani JN; Straus Farber R; Zaslavsky E; Nudelman G; Raine CS; John GR
Brain; 2015 Jun; 138(Pt 6):1548-67. PubMed ID: 25805644
[TBL] [Abstract][Full Text] [Related]
26. [Inhibitory effect of miR-429 on expressions of ZO-1, Occludin, and Claudin-5 proteins to improve the permeability of blood spinal cord barrier
Sun R; Yu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Sep; 34(9):1163-1169. PubMed ID: 32929911
[TBL] [Abstract][Full Text] [Related]
27. Claudin-5a is essential for the functional formation of both zebrafish blood-brain barrier and blood-cerebrospinal fluid barrier.
Li Y; Wang C; Zhang L; Chen B; Mo Y; Zhang J
Fluids Barriers CNS; 2022 Jun; 19(1):40. PubMed ID: 35658877
[TBL] [Abstract][Full Text] [Related]
28. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
29. ApoE-deficient promotes blood-brain barrier disruption in experimental autoimmune encephalomyelitis via alteration of MMP-9.
Zheng M; Wei J; Tang Y; Yang C; Wei Y; Yin X; Liu Q
J Mol Neurosci; 2014; 54(2):282-90. PubMed ID: 24788224
[TBL] [Abstract][Full Text] [Related]
30. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
[TBL] [Abstract][Full Text] [Related]
31. Central nervous system penetration for small molecule therapeutic agents does not increase in multiple sclerosis- and Alzheimer's disease-related animal models despite reported blood-brain barrier disruption.
Cheng Z; Zhang J; Liu H; Li Y; Zhao Y; Yang E
Drug Metab Dispos; 2010 Aug; 38(8):1355-61. PubMed ID: 20427691
[TBL] [Abstract][Full Text] [Related]
32. Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.
Watson PM; Paterson JC; Thom G; Ginman U; Lundquist S; Webster CI
BMC Neurosci; 2013 Jun; 14():59. PubMed ID: 23773766
[TBL] [Abstract][Full Text] [Related]
33. Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis.
Tezuka K; Suzuki M; Sato R; Kawarada S; Terasaki T; Uchida Y
J Neurochem; 2022 Mar; 160(6):662-674. PubMed ID: 35064931
[TBL] [Abstract][Full Text] [Related]
34. Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Lanz TV; Becker S; Osswald M; Bittner S; Schuhmann MK; Opitz CA; Gaikwad S; Wiestler B; Litzenburger UM; Sahm F; Ott M; Iwantscheff S; Grabitz C; Mittelbronn M; von Deimling A; Winkler F; Meuth SG; Wick W; Platten M
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14735-40. PubMed ID: 23959874
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.
Tonra JR; Reiseter BS; Kolbeck R; Nagashima K; Robertson R; Keyt B; Lindsay RM
J Comp Neurol; 2001 Jan; 430(1):131-44. PubMed ID: 11135250
[TBL] [Abstract][Full Text] [Related]
36. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
[TBL] [Abstract][Full Text] [Related]
37. Defining the role of NG2-expressing cells in experimental models of multiple sclerosis. A biofunctional analysis of the neurovascular unit in wild type and NG2 null mice.
Girolamo F; Errede M; Longo G; Annese T; Alias C; Ferrara G; Morando S; Trojano M; Kerlero de Rosbo N; Uccelli A; Virgintino D
PLoS One; 2019; 14(3):e0213508. PubMed ID: 30870435
[TBL] [Abstract][Full Text] [Related]
38. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
39. Blood-arachnoid barrier disruption in experimental rat meningitis detected using gadolinium-enhancement ratio imaging.
Ichikawa H; Itoh K
Brain Res; 2011 May; 1390():142-9. PubMed ID: 21435335
[TBL] [Abstract][Full Text] [Related]
40. Disturbed function of the blood-cerebrospinal fluid barrier aggravates neuro-inflammation.
Kooij G; Kopplin K; Blasig R; Stuiver M; Koning N; Goverse G; van der Pol SM; van Het Hof B; Gollasch M; Drexhage JA; Reijerkerk A; Meij IC; Mebius R; Willnow TE; Müller D; Blasig IE; de Vries HE
Acta Neuropathol; 2014 Aug; 128(2):267-77. PubMed ID: 24356983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
